The prevalence and management of co-morbid substance misuse and mental illness: Results of a screening survey in substance misuse and mental health treatment populations

Drug and Alcohol Review

Volumn 20, Issue 4, 2001, Pages 407-416

  Weaver, Tim ^a,b   Hickman, Matthew ^a,b   Rutter, Deborah ^b   Ward, Jenni ^a,b   Stimson, Gerry ^a,b   Renton, Adrian ^a,b  

^a Ctr Res Drugs and Hlth Behaviour   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Clinical management; Co morbid substance misuse and mental illness; Prevalence

Indexed keywords

EID: 0035729916     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230120092724     Document Type: Article

References (36)

1. All Party Parliamentary Drugs Misuse Group. Drug misuse and mental health: learning lessons on dual diagnosis. Report of the all party parliamentary drugs misuse group, House of Commons, 2000.
2. Appleby L, Shaw J, Amos T, McDonnell R, Kiernan K, Davies S. Safer services: national confidential inquiry into suicides and homicides by people with mental illness. London: Stationery Office, 1999.
3. Johnson S. Dual diagnosis of severe mental illness and substance misuse: a case for specialist services? Br J Psychiatry 1997;171:205-8.
4. Weaver T, Renton A, Stimson G, Tyrer P. Severe mental illness and substance misuse co-morbidity: Research is needed to inform policy and service development. Br Med J 1999;318:137-8.
5. Drake RE, Wallach MA. Substance abuse among the chronically mentally ill. Hosp Community Psychiatry 1989;40:1041-5.
6. Carey MP, Carey KB, Meisler AW. Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 1991;179:136-8.
7. Brooner RK, King VL, Kidorf M, Schmidt Jr CW, Bigelow GE. Psychiatric and substance misuse co-morbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71-80.
8. Driessen M, Veltrup C, Weber J, John U, Wetterling T, Dilling, H. Psychiatric co-morbidity, suicidal behaviour and suicidal ideation in alcoholics seeking treatment. Addiction 1998;93:889-94.
9. Pristach C, Smith C. Medication compliance and substance abuse among schizophrenic patients. Hosp Community Psychiatry 1990;41:1345-8.
10. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA. Predicting the 'revolving door' phenomenon among patients with schizophrenic, schizoaffective and affective disorders. Am J Psychiatry 1995;152:856-61.
11. Dickey B, Azeni H. Persons with dual diagnosis of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health 1996;86:973-77.
12. Swartz MS, Swanson JW, Hiday VA, Borum R, Wagner HR, Burns BJ. Violence and severe mental illness: the effects of substance abuse and non-adherence to medication. Am J Psychiatry 1998;155:226-31.
13. Scott H, Johnson S, Menezes P et al. Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 1998;172:345-50.
14. Reigier DA, Farmer ME, Rae DS et al. Co-morbidity of mental disorder with alcohol and other drug abuse: results from an epidemiological catchment area (ECA) study. JAMA 1990;264:2511-18.
15. Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12 month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19.
16. Hall W. What have population surveys revealed about substance use disorders and their co-morbidity with other mental disorders? Drug Alcohol Rev 1996;15:157-70.
17. Jenkins R, Bebbington P, Brugha TS, Farrell M, Lewis G, Meltzer H. British Psychiatric Morbidity Survey. Br J Psychiatry 1998;173:4-7.
18. Duke P, Pantelis C, Barnes TRE. South Westminster Schizophrenia Survey: alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994;164:630-6.
19. Menezes PR, Johnson S, Thornicroft G et al. Drug and alcohol problems among individuals with severe mental illness in South London. Br J Psychiatry 1996;168:612-19.
20. McPhillips MA, Kelly FJ, Barnes TRE, Duke PJ, Gene-Cos N, Clark K. Detecting co-morbid substance abuse among people with schizophrenia living in the community: a study comparing the results of questionnaires with analysis of hair and urine. Schizophr Res 1997;25:141-8.
21. McPhillips MA, Strang J, Barnes TRE. Hair analysis: new laboratory ability to test for substance use. Br J Psychiatry 1998;173:287-90.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
23. Osher FC, Drake RE. Reversing a history of unmet needs: approaches to care for persons with co-occurring addictive and mental disorders. Am J Orthopsychiatry 1996;66:4-11.
24. Ramsay M, Partridge S. Drug misuse declared in 1998: results from the British Crime Survey. London: Home Office, Research and Statistics Directorate, 1999.
25. Johnson S, Ramsay R, Thornicroft G et al., eds. London's Mental Health: the report to the Kings Fund London Commission. London, Kings Fund Publishing, 1997.
26. Kisely S. More alike than different: comparing the mental health needs of London and other inner city areas. J Public Health Med 1998;20: 318-24.
27. Soyka M, Albus M, Kathman N et al. Prevalence of alcohol and drug abuse in schizophrenic inpatients. Eur Arch Psychiatry Clin Neurosci 1993;242: 362-72.
28. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998;24:443-55.
29. Tyrer P, Casey P, Ferguson B. Personality disorder in perspective. Br J Psychiatry 1991;159: 463-71.
30. Roth A, Fonagy P. What works for whom? A critical review of psychotherapy research. London, Guilford Press, 1996.
31. Hall W, Farrell M. Co-morbidity of mental disorders with substance misuse. Br J Psychiatry 1997;171: 4-5.
32. Department of Health. Building bridges: a guide to inter-agency working for the care and protection of severely mentally ill people. London, Department of Health, 1995.
33. Department of Health. Modernising mental health services. London, Department of Health, 1998.
34. Lehman AF, Dixon LB, eds. Double jeopardy: chronic mental illness and substance use disorders. Switzerland: Hanwood Academic Publishers, 1995: 251-64.
35. Drake RE, Noordsy DL, Ackerson T. Integrating mental health and substance abuse treatments. In: Lehman AF, Dixon LB, eds. Double jeopardy: chronic mental illness and substance use disorders. Switzerland: Hanwood Academic Publishers, 1995.
36. Ley A, Jeffery DP, Mclaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 1999.